Apollomics, Inc. (APLM)
APLM Stock Price Chart
Explore Apollomics, Inc. interactive price chart. Choose custom timeframes to analyze APLM price movements and trends.
APLM Company Profile
Discover essential business fundamentals and corporate details for Apollomics, Inc. (APLM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 Nov 2021
Employees
13.00
Website
https://www.apollomicsinc.comCEO
Guo-Liang Yu
Description
Apollomics, Inc., a biotechnology company, engages in the discovery and development of oncology therapies to address unmet medical needs in California, Hangzhou, Shanghai, China, and Australia. It develops APL-101 (Vebreltinib), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors; APL-102 is an oral active, small molecule multiple tyrosine kinase inhibitor for liver cancer, breast cancer, and esophageal cancer; and APL-122, a tumor inhibitor candidate to treat cancers within the brain. The company was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated in 2015 and is based in Foster City, California.
APLM Financial Timeline
Browse a chronological timeline of Apollomics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 3 Jul 2025
Earnings released on 3 Apr 2025
Stock split effective on 25 Nov 2024
Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 25 Nov 2024
Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Aug 2024
EPS came in at -$18.78 , while revenue for the quarter reached $967.50K .
Earnings released on 27 Jun 2024
EPS came in at -$18.78 falling short of the estimated -$0.17 by -10.95K%, while revenue for the quarter reached $967.50K .
Earnings released on 28 Mar 2024
EPS came in at -$12.19 falling short of the estimated -$0.16 by -7.52K%, while revenue for the quarter reached $166.50K .
Earnings released on 28 Sept 2023
EPS came in at -$12.19 falling short of the estimated -$0.16 by -7.52K%, while revenue for the quarter reached $166.50K .
Earnings released on 28 Jul 2023
EPS came in at -$127.71 falling short of the estimated -$0.16 by -79.72K%, while revenue for the quarter reached $244.00K .
Earnings released on 28 Apr 2023
EPS came in at -$408.26 , while revenue for the quarter reached -$136.00K .
Earnings released on 31 Mar 2023
EPS came in at -$127.71 , while revenue for the quarter reached $244.00K .
Earnings released on 29 Sept 2022
EPS came in at -$0.07 , while revenue for the quarter reached -$136.00K .
Earnings released on 30 Jun 2022
EPS came in at -$1.76 .
Earnings released on 30 Mar 2022
EPS came in at -$2.65 .
Earnings released on 31 Dec 2021
EPS came in at -$1.28 .
Earnings released on 30 Jun 2021
EPS came in at -$8.79 , while revenue for the quarter reached $27.50K .
Earnings released on 31 Mar 2021
EPS came in at -$8.79 , while revenue for the quarter reached $27.50K .
Earnings released on 31 Dec 2020
EPS came in at -$8.75 .
APLM Stock Performance
Access detailed APLM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.